[1] |
Johansen JD, Aalto⁃Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing⁃recommendations on best practice[J]. Contact Dermatitis, 2015,73(4):195⁃221. doi: 10.1111/cod.12432.
|
[2] |
Eskew AM, Bedrick BS, Hardi A, et al. Letrozole compared with clomiphene citrate for unexplained infertility: a systematic review and meta⁃analysis[J]. Obstet Gynecol, 2019,133(3):437⁃444. doi: 10.1097/AOG.0000000000003105.
|
[3] |
Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence⁃based guideline for the assessment and management of polycystic ovary syndrome[J]. Fertil Steril, 2018,110(3):364⁃379. doi: 10.1016/j.fertnstert.2018.05.004.
|
[4] |
Bozkaya Y, Erdem GU, Demirci NS. In case of anastrozole⁃related hallucinations, can switching to letrozole be a treatment option? A case report and literature review[J]. J Oncol Pharm Pract, 2019,25(3):754⁃757. doi: 10.1177/1078155218762626.
|
[5] |
Chia WK, Lim YL, Greaves MW, et al. Toxic epidermal necrolysis in patient with breast cancer receiving letrozole[J]. Lancet Oncol, 2006,7(2):184⁃185. doi: 10.1016/S1470⁃2045(06)70581⁃2.
|
[6] |
Jhaveri K, Halperin P, Shin SJ, et al. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature[J]. Breast Cancer Res Treat, 2007,106(3):315⁃318. doi: 10.1007/s10549⁃007⁃9518⁃7.
|
[7] |
Sarradin V, Dalenc F, Sibaud V, et al. Acute generalized exanthematous pustulosis induced by docetaxel and recurrent with letrozole: a case report[J]. Clin Breast Cancer, 2018,18(5):e743⁃e746. doi: 10.1016/j.clbc.2018.06.009.
|
[8] |
Tripathy A, Kumari KM, Babu AVM, et al. Anything rare is possible: letrozole induced eczematous skin eruption[J]. J Clin Diagn Res, 2014,8(6):YD03⁃04. doi: 10.7860/JCDR/2014/9028.4498.
|
[9] |
Yamamoto D, Yamamoto C, Yamamoto M. A case of interstitial pneumonitis induced by lapatinib plus letrozole[J]. Gan To Kagaku Ryoho, 2016,43(12):2059⁃2061.
|